FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely neurology, and can be used in the treatment of cavernous nerve damage. Use of the invention comprises administering neuregulin in order to treat damage to the cavernous nerves.
EFFECT: use of the invention allows to improve the function of the cavernous nerves, when they are damaged as a result of trauma or surgical procedure.
18 cl, 7 dwg, 4 ex
| Title |
Year |
Author |
Number |
| USING NEUREGULIN FOR TREATING PERIPHERAL NERVES INJURY |
2018 |
- Caggiano, Anthony, O.
- Bella, Anthony, J.
- Iaci, Jennifer, F.
|
RU2715908C2 |
| USING NEUREGULIN FOR TREATING PERIPHERAL NERVE INJURY |
2010 |
- Kadzhano Ehntoni O.
- Bella Ehntoni Dzh.
- Ajasi Dzhennifer F.
|
RU2575570C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT DURING NON-ACUTE PERIODS FOLLOWING NEUROLOGICAL CNS DAMAGE |
2013 |
- Kadzhano Entoni
- Ajasi Dzhennifer
|
RU2646507C2 |
| METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS |
2014 |
- Kim Khaesun
- Kadzhano Entoni O.
|
RU2687097C2 |
| THERAPEUTIC DOSING OF NEUREGULIN OR ITS SUB-SEQUENCE FOR TREATING OR PREVENTING HEART FAILURE |
2014 |
- Kadzhano Entoni
- Ganguli Anindita
- Ajasi Dzhennifer
- Perri Tom
|
RU2698090C2 |
| COMPOSITIONS AND METHODS FOR TREATING NON-ACUTE PERIODS FOLLOWING NEUROLOGICAL DAMAGE |
2009 |
- Kadzhano Ehntoni
- Ajasi Dzhennifer
|
RU2501564C2 |
| THERAPEUTIC DOSING OF NEUREGULIN OR ITS SUB-SEQUENCE FOR TREATING OR PREVENTING HEART FAILURE |
2019 |
- Kadzhano, Entoni
- Ganguli, Anindita
- Ajasi, Dzhennifer
- Perri, Tom
|
RU2719199C1 |
| METHOD OF PROVIDING REQUIRED LEVELS OF GLIAL GROWTH FACTOR 2 IN PLASMA |
2009 |
- Kim Khaesun
- Kadzhano Ehntoni O.
|
RU2530650C2 |
| APPLICATION OF PEPTIDE GGF2 IN TREATMENT OR PREVENTION OF HEART FAILURE IN MAMMALS |
2009 |
- Kadzhano Ehntoni
- Ganguli Anindita
- Ajasi Dzhennifer
- Pehrri Tom
|
RU2536938C2 |
| AGENT FOR TREATING ERECTILE DYSFUNCTION |
2019 |
- Platova Angelina Igorevna
- Korobov Nikolaj Vasilevich
|
RU2727506C1 |
